Free Trial

Estrella Immunopharma (ESLA) Stock Price, News & Analysis

Estrella Immunopharma logo
$0.96 +0.02 (+2.13%)
Closing price 03:56 PM Eastern
Extended Trading
$0.95 -0.01 (-0.63%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Estrella Immunopharma Stock (NASDAQ:ESLA)

Key Stats

Today's Range
$0.94
$1.05
50-Day Range
$0.82
$0.99
52-Week Range
$0.63
$1.78
Volume
104,203 shs
Average Volume
105,104 shs
Market Capitalization
$35.58 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$16.00
Consensus Rating
Buy

Company Overview

Estrella Immunopharma Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
63rd Percentile Overall Score

ESLA MarketRank™: 

Estrella Immunopharma scored higher than 63% of companies evaluated by MarketBeat, and ranked 396th out of 949 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Estrella Immunopharma has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Estrella Immunopharma has only been the subject of 1 research reports in the past 90 days.

  • Read more about Estrella Immunopharma's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Estrella Immunopharma is -3.92, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Estrella Immunopharma is -3.92, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Read more about Estrella Immunopharma's valuation and earnings.
  • Percentage of Shares Shorted

    1.61% of the float of Estrella Immunopharma has been sold short.
  • Short Interest Ratio / Days to Cover

    Estrella Immunopharma has a short interest ratio ("days to cover") of 0.9, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Estrella Immunopharma has recently decreased by 17.02%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Estrella Immunopharma does not currently pay a dividend.

  • Dividend Growth

    Estrella Immunopharma does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    1.61% of the float of Estrella Immunopharma has been sold short.
  • Short Interest Ratio / Days to Cover

    Estrella Immunopharma has a short interest ratio ("days to cover") of 0.9, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Estrella Immunopharma has recently decreased by 17.02%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Estrella Immunopharma has a news sentiment score of 1.87. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.99 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Estrella Immunopharma this week, compared to 0 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Estrella Immunopharma insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    55.10% of the stock of Estrella Immunopharma is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 0.35% of the stock of Estrella Immunopharma is held by institutions.

  • Read more about Estrella Immunopharma's insider trading history.
Receive ESLA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Estrella Immunopharma and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ESLA Stock News Headlines

Estrella Immunopharma (NASDAQ:ESLA) Trading Up 1% - Should You Buy?
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.tc pixel
ESLA Estrella Immunopharma, Inc.
See More Headlines

ESLA Stock Analysis - Frequently Asked Questions

Estrella Immunopharma's stock was trading at $1.20 at the start of the year. Since then, ESLA stock has decreased by 15.0% and is now trading at $1.02.

Shares of ESLA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Estrella Immunopharma investors own include NuCana (NCNA), Cardio Diagnostics (CDIO), Caribou Biosciences (CRBU), GRI Bio (GRI), Intrusion (INTZ), Lonestar Resources US (LONE) and Children's Place (PLCE).

Company Calendar

Today
8/28/2025
Next Earnings (Estimated)
9/26/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:ESLA
CIK
1844417
Fax
N/A
Employees
N/A
Year Founded
N/A

Price Target and Rating

High Price Target
$16.00
Low Price Target
$16.00
Potential Upside/Downside
+1,566.7%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.26)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-1,132.38%
Return on Assets
-358.54%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.16
Quick Ratio
0.16

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.16) per share
Price / Book
-6.00

Miscellaneous

Outstanding Shares
37,066,000
Free Float
16,643,000
Market Cap
$35.58 million
Optionable
Not Optionable
Beta
0.34
Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

This page (NASDAQ:ESLA) was last updated on 8/28/2025 by MarketBeat.com Staff
From Our Partners